Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6645.T Stock Summary
Top 10 Correlated ETFs
6645.T
In the News
6645.T Financial details
Company Rating
Neutral
Market Cap
1048.99B
Income
31.19B
Revenue
846.09B
Book val./share
3824.49
Cash/share
656.67
Dividend
49
Dividend %
0.73%
Employees
28.03K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
25.3
Forward P/E
-
PEG
-5.25
P/S
1.42
P/B
1.73
P/C
7.63
P/FCF
88.14
Quick Ratio
1.36
Current Ratio
2.58
Debt / Equity
0.15
LT Debt / Equity
0.01
-
-
EPS (TTM)
158.38
EPS next Y
-
EPS next Q
-
EPS this Y
21.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.37%
Revenue last 5Y
0.38%
Revenue Q/Q
5.06%
EPS Q/Q
-124.13%
-
-
-
-
SMA20
-5.96%
SMA50
-19.28%
SMA100
-14.52%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
7%
ROC
0.1%
Gross Margin
44%
Oper. Margin
9%
Profit Margin
6%
Payout
37%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5245.0-9329.0
52W High
-46.28%
52W Low
-4.44%
RSI
31
Rel Volume
0.93
Avg Volume
1.22M
Volume
1.14M
Perf Week
-5.33%
Perf Month
-10.24%
Perf Quarter
-18.18%
Perf Half Y
-21.55%
-
-
-
-
Beta
1.071
-
-
Volatility
121.27%, 171.61%
Prev Close
-1.3%
Price
5012
Change
-0.75%
6645.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.13K | 3.31K | 3.25K | 3.8K | 4.41K | |
Net income per share | 260.78 | 365.26 | 214.72 | 305.65 | 372.19 | |
Operating cash flow per share | 342.02 | 437.89 | 465.22 | 335.66 | 269.37 | |
Free cash flow per share | 154.58 | 254.37 | 333.03 | 169.61 | 42.52 | |
Cash per share | 529.27 | 904.84 | 1.24K | 605.22 | 221.57 | |
Book value per share | 2.42K | 2.59K | 3.01K | 3.31K | 3.67K | |
Tangible book value per share | 2.24K | 2.29K | 2.71K | 3K | 3.34K | |
Share holders equity per share | 2.42K | 2.59K | 3.01K | 3.31K | 3.67K | |
Interest debt per share | 0 | 150.65 | 192.81 | 299.26 | 228.61 | |
Market cap | 1108.19B | 1154.4B | 1742.62B | 1650.05B | 1529.44B | |
Enterprise value | 997.94B | 999.76B | 1530.76B | 1554.68B | 1469.53B | |
P/E ratio | 20.4 | 15.41 | 40.24 | 26.87 | 20.71 | |
Price to sales ratio | 1.29 | 1.7 | 2.66 | 2.16 | 1.75 | |
POCF ratio | 15.55 | 12.86 | 18.57 | 24.47 | 28.61 | |
PFCF ratio | 34.42 | 22.13 | 25.94 | 48.43 | 181.26 | |
P/B Ratio | 2.2 | 2.18 | 2.87 | 2.48 | 2.1 | |
PTB ratio | 2.2 | 2.18 | 2.87 | 2.48 | 2.1 | |
EV to sales | 1.16 | 1.47 | 2.34 | 2.04 | 1.68 | |
Enterprise value over EBITDA | 9.42 | 12.43 | 17.43 | 14.12 | 11.76 | |
EV to operating cash flow | 14.01 | 11.13 | 16.31 | 23.06 | 27.49 | |
EV to free cash flow | 30.99 | 19.17 | 22.79 | 45.63 | 174.16 | |
Earnings yield | 0.05 | 0.06 | 0.02 | 0.04 | 0.05 | |
Free cash flow yield | 0.03 | 0.05 | 0.04 | 0.02 | 0.01 | |
Debt to equity | 0 | 0.06 | 0.06 | 0.09 | 0.06 | |
Debt to assets | 0 | 0.04 | 0.05 | 0.06 | 0.05 | |
Net debt to EBITDA | -1.04 | -1.92 | -2.41 | -0.87 | -0.48 | |
Current ratio | 2.5 | 2.96 | 3.19 | 2.28 | 2.32 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.3 | 1.19 | 2.14 | 1.09 | 0.72 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.31 | 0.23 | 0.39 | 0.29 | 0.26 | |
Sales general and administrative to revenue | 0.26 | 0.3 | 0.29 | 0.28 | 0.28 | |
Research and developement to revenue | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.55 | -0.42 | -0.28 | -0.49 | -0.84 | |
Capex to revenue | -0.05 | -0.06 | -0.04 | -0.04 | -0.05 | |
Capex to depreciation | -1.28 | -1.32 | -1.17 | -1.43 | -1.69 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.77K | 4.61K | 3.81K | 4.77K | 5.54K | |
ROIC | 0.1 | 0.07 | 0.07 | 0.09 | 0.09 | |
Return on tangible assets | 0.08 | 0.1 | 0.06 | 0.07 | 0.08 | |
Graham Net | 285.22 | 549.48 | 952.79 | 214.83 | -8.04 | |
Working capital | 257.19B | 295.84B | 353.06B | 271.23B | 276.87B | |
Tangible asset value | 465.78B | 494.02B | 570.2B | 628.25B | 688.1B | |
Net current asset value | 185.1B | 221.6B | 303.41B | 220.25B | 219.96B | |
Invested capital | 0 | 0.06 | 0.06 | 0.09 | 0.06 | |
Average receivables | 171.6B | 152.14B | 134.22B | 142.71B | 165.11B | |
Average payables | 91.51B | 76.87B | 67.03B | 78.19B | 89.84B | |
Average inventory | 129.83B | 117.19B | 103.78B | 122.6B | 157.93B | |
Days sales outstanding | 72.3 | 72.16 | 74.84 | 72.25 | 74.66 | |
Days payables outstanding | 64.45 | 62.9 | 71.08 | 76.16 | 70.29 | |
Days of inventory on hand | 93.95 | 101.72 | 105.53 | 124.5 | 131.65 | |
Receivables turnover | 5.05 | 5.06 | 4.88 | 5.05 | 4.89 | |
Payables turnover | 5.66 | 5.8 | 5.13 | 4.79 | 5.19 | |
Inventory turnover | 3.89 | 3.59 | 3.46 | 2.93 | 2.77 | |
ROE | 0.11 | 0.14 | 0.07 | 0.09 | 0.1 | |
Capex per share | -187.44 | -183.52 | -132.19 | -166.05 | -226.85 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.18K | 1.21K | 1.03K | 1K | 1.05K | |
Net income per share | 114.26 | 118.55 | 68.06 | -37.21 | 8.98 | |
Operating cash flow per share | 5.99 | 168.67 | 39.9 | 90.93 | 31.07 | |
Free cash flow per share | -45.66 | 82.16 | -6.91 | 42.08 | -29.65 | |
Cash per share | 324.9 | 345.75 | 48.32 | 547.85 | 656.67 | |
Book value per share | 3.58K | 3.7K | 3.9K | 3.87K | 3.82K | |
Tangible book value per share | 3.37K | 3.36K | 3.68K | 3.64K | 2.36K | |
Share holders equity per share | 3.58K | 3.7K | 3.9K | 3.87K | 3.82K | |
Interest debt per share | 191.04 | 230.4 | 234.09 | 227.85 | 577.56 | |
Market cap | 1269.26B | 1517.61B | 1725.88B | 1310.83B | 1296.32B | |
Enterprise value | 1219.56B | 1457.7B | 1674.25B | 1247.91B | 1318.03B | |
P/E ratio | 14.01 | 16.25 | 32.21 | -44.79 | 183.2 | |
Price to sales ratio | 5.43 | 6.37 | 8.49 | 6.64 | 6.25 | |
POCF ratio | 1.07K | 45.69 | 219.75 | 73.32 | 211.85 | |
PFCF ratio | -140.27 | 93.8 | -1.27K | 158.45 | -222.01 | |
P/B Ratio | 1.79 | 2.08 | 2.25 | 1.72 | 1.72 | |
PTB ratio | 1.79 | 2.08 | 2.25 | 1.72 | 1.72 | |
EV to sales | 5.22 | 6.12 | 8.23 | 6.32 | 6.36 | |
Enterprise value over EBITDA | 31.67 | 42.18 | 65.77 | 93.33 | 91.69 | |
EV to operating cash flow | 1.03K | 43.89 | 213.17 | 69.8 | 215.4 | |
EV to free cash flow | -134.77 | 90.1 | -1.23K | 150.84 | -225.73 | |
Earnings yield | 0.02 | 0.02 | 0.01 | -0.01 | 0 | |
Free cash flow yield | -0.01 | 0.01 | 0 | 0.01 | 0 | |
Debt to equity | 0.05 | 0.06 | 0.06 | 0.06 | 0.15 | |
Debt to assets | 0.04 | 0.05 | 0.05 | 0.04 | 0.09 | |
Net debt to EBITDA | -1.29 | -1.73 | -2.03 | -4.71 | 1.51 | |
Current ratio | 2.49 | 2.32 | 2.65 | 2.58 | 1.88 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.05 | 1.42 | 0.58 | -2.52 | 3.46 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Payout ratio | 0.43 | 0 | 0.72 | 0 | 5.79 | |
Sales general and administrative to revenue | 0.26 | 0.27 | 0.31 | 0.32 | 0.33 | |
Research and developement to revenue | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 | |
Intangibles to total assets | 0.05 | 0.04 | 0.05 | 0.05 | 0.35 | |
Capex to operating cash flow | -8.62 | -0.51 | -1.17 | -0.54 | -1.95 | |
Capex to revenue | -0.04 | -0.07 | -0.05 | -0.05 | -0.06 | |
Capex to depreciation | -1.51 | -2.5 | -1.34 | -1.38 | -1.41 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.03K | 3.14K | 2.44K | 1.8K | 879.22 | |
ROIC | 0.03 | 0.03 | 0.01 | 0 | 0 | |
Return on tangible assets | 0.03 | 0.02 | 0.01 | -0.01 | 0 | |
Graham Net | 221.81 | 114.35 | -88.53 | 355.15 | -152.55 | |
Working capital | 279.69B | 276.87B | 303.9B | 300.32B | 245.31B | |
Tangible asset value | 668.41B | 688.1B | 723.59B | 715.69B | 465.19B | |
Net current asset value | 235B | 219.96B | 247.18B | 244.13B | 155.7B | |
Invested capital | 0.05 | 0.06 | 0.06 | 0.06 | 0.15 | |
Average receivables | 151.72B | 168.76B | 168.79B | 154.98B | 152.23B | |
Average payables | 97.95B | 95.05B | 89.06B | 82.78B | 83.53B | |
Average inventory | 185.31B | 180.69B | 182.67B | 190.74B | 189.01B | |
Days sales outstanding | 61 | 67.74 | 70.1 | 69.13 | 66.37 | |
Days payables outstanding | 68.26 | 63.79 | 68.04 | 62.38 | 64.45 | |
Days of inventory on hand | 131.58 | 119.49 | 152.72 | 147.67 | 139.61 | |
Receivables turnover | 1.48 | 1.33 | 1.28 | 1.3 | 1.36 | |
Payables turnover | 1.32 | 1.41 | 1.32 | 1.44 | 1.4 | |
Inventory turnover | 0.68 | 0.75 | 0.59 | 0.61 | 0.64 | |
ROE | 0.03 | 0.03 | 0.02 | -0.01 | 0 | |
Capex per share | -51.66 | -86.51 | -46.81 | -48.85 | -60.73 |
6645.T Frequently Asked Questions
What is OMRON Corporation stock symbol ?
OMRON Corporation is a JP stock and trading under the symbol 6645.T
What is OMRON Corporation stock quote today ?
OMRON Corporation stock price is $5012 today.
Is OMRON Corporation stock public?
Yes, OMRON Corporation is a publicly traded company.